Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,103 recalls, newest first

Class I · High risk

Super Samurai-X

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Terminated Chemical / undeclared SOS Telecom Inc. D-0104-2017
Class I · High risk

Ginseng Power-X

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Terminated Chemical / undeclared SOS Telecom Inc. D-0103-2017
Class I · High risk

Ninja-X

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Terminated Chemical / undeclared SOS Telecom Inc. D-0102-2017
Class I · High risk

Tiger-X

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Terminated Chemical / undeclared SOS Telecom Inc. D-0101-2017

Recalls by year